Checkpoint inhibitors increase median survival to 12.4 months, and more than double percentage of patients who survive 4 years or longer.
Browsing: brain tumor
Researchers have reported that children with incurable brain tumors could benefit from a potentially life-extending treatment, if genetic testing is utilized to personalize their therapy. This personalized treatment has previously only been used in adults.
In partnership with The Brain Tumour Charity, the awards hope to tackle six major themes in brain tumor research.
Novel research has indicated a distinct group of circulating tumor cells that are associated with breast cancer brain metastases, the findings may help detect the tumors while they are still treatable.
Researchers have uncovered the role of cellular prion protein (PrPC) in Neurofibromatosis Type 2 (NF2) related tumors, offering hope to neuro-tumor patients.
Possible damage to immune-privileged sites in natural killer cell therapy in cancer patients: side effects of natural killer cell therapy
Find out in this perspective article how cytotoxic and expanded NK cells induced in cancer patients may be turned into pathogenic factors if they enter immune-privileged microenvironments in susceptible individuals.
New research from the University of Edinburgh highlights how an olive oil component, oleic acid, inhibits cancer-causing proteins in the brain.
This review reports the results of application of short peptides in glioma therapy clinical trials, their rises and falls.
Does Graded Prognostic Assessment outperform Recursive Partitioning Analysis in patients with moderate prognosis brain metastases?
Primary research to evaluate whether Recursive Partitioning Analysis or Graded Prognostic Assessment is more useful to clinicians.
A team of investigators on the Head Start III trial have highlighted that patients with reduced radiotherapy experience a worse prognosis following deviations from the treatment protocol.